0
0

To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.

1/12/2024, 8:16 AM

Congressional Summary of HR 6979

This bill allows certain small businesses a new tax credit for 10% of their qualified drug threat mitigation research expenses. Such expenses include research into mitigating or treating the effects of specified drugs, including any emerging drugs, fentanyl, a fentanyl-related substance, or methamphetamine.

Current Status of Bill HR 6979

Bill HR 6979 is currently in the status of Bill Introduced since January 11, 2024. Bill HR 6979 was introduced during Congress 118 and was introduced to the House on January 11, 2024.  Bill HR 6979's most recent activity was Referred to the House Committee on Ways and Means. as of January 11, 2024

Bipartisan Support of Bill HR 6979

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
5
Democrat Cosponsors
2
Republican Cosponsors
3
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 6979

Primary Policy Focus

Alternate Title(s) of Bill HR 6979

To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.
To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.

Comments